GA
CPRX

Guerra Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Guerra Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$630 Buy
+32
New +$658 ﹤0.01% 789

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Guerra Advisors's CPRX Position: Q3 2025 in Review

Guerra Advisors opened a new position in Catalyst Pharmaceutical (CPRX) in Q3 2025: 32 shares worth $630. The stake represents ﹤0.01% of the portfolio and ranks #789 among its holdings.

360 funds tracked by Wall St. Rank hold CPRX as of Q3 2025.

  • Guerra Advisors held 32 shares of Catalyst Pharmaceutical worth $630 as of Q3 2025.
  • Catalyst Pharmaceutical was a new Guerra Advisors position in Q3 2025.
  • Catalyst Pharmaceutical made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #789 holding.
  • 360 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.